BPC-157 + PEA 500

BPC-157 + PEA 500 is a blend of BPC-157 (Arginine Salt) and Palmitoylethanolamide (PEA), along with Salcaprozate sodium (SNAC) for enhanced absorption. BPC-157 is a peptide derived from human gastric juice, known for its potential to support repair, recovery, and various health benefits. It has been studied for its role in tendon repair, gastric ulcer healing, inflammation reduction, and neuroprotection.

Tendon repair is one of the potential benefits of BPC-157. It aids in the regeneration and repair of damaged tendons, which can help reduce recovery time and improve outcomes following tendon injuries.

BPC-157 has also shown promise in promoting the healing of gastric ulcers, a type of peptic ulcer that occurs in the stomach lining. It has been found to facilitate the healing process and alleviate symptoms associated with gastric ulcers.

In terms of gastrointestinal health, BPC-157 has demonstrated potential in supporting inflammatory bowel disease (IBD). Animal studies have shown that it can reduce inflammation and improve symptoms associated with IBD, such as abdominal pain, diarrhea, and weight loss.

What makes BPC-157 unique is its oral bioavailability, particularly in the form of the arginate salt used in this formulation. To further enhance its absorption, Salcaprozate sodium (SNAC) has been included in the blend. SNAC is an intestinal permeation enhancer that has been tested in clinical trials for the oral delivery of macromolecules. It improves the absorption of peptides without affecting tight junctions.

Palmitoylethanolamide (PEA) is another key component of BPC-157 + PEA 500. PEA is a naturally occurring fatty acid that has been extensively studied for its therapeutic properties. It supports the inflammatory response, helps reduce pain, and restores balance in the endocannabinoid system. PEA's anti-inflammatory effects involve inhibiting the production of pro-inflammatory cytokines and modulating microglia cell activity. It also offers neuroprotection by reducing reactive oxygen species levels and modulating cell death pathways.

PEA's role in the endocannabinoid system is significant, especially in the gut. It plays a key role in the gut-brain axis and modulates gastrointestinal motility, secretion, and inflammation. PEA has shown effectiveness in reducing symptoms of irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and other digestive disorders. Clinical trials have demonstrated its ability to alleviate symptoms such as abdominal pain, bloating, heartburn, and acid reflux.

The combination of BPC-157 and PEA in BPC-157 + PEA 500 provides a synergistic effect, supporting full-body repair, regeneration, and various aspects of gastrointestinal health.